General Oncology, Inc. — Form D/A

General Oncology, Inc. of Newton, MA, a company, filed a Form D amendment with the SEC on 2022-12-22. The offering totals $7.5M, of which $3.2M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (18)

NameRoleLocation
Michael J PetitDirectorBrookline, MA
Arnold Aaron GlazierDirectorBrookline, MA
Arnold Aaron GlazierExecutive OfficerBrookline, MA
Abid J AnsariExecutive OfficerBrookline, MA
Barry J SeemanDirectorBrookline, MA
Jeffrey Aaron GlazierDirectorNewton, MA
Jeffrey Aaron GlazierExecutive OfficerNewton, MA
Jeffrey Aaron GlazierRelated PersonNewton, MA
Gregg GoldsteinDirectorBrookline, MA
Gregg GoldsteinExecutive OfficerBrookline, MA
Arnold GlazierDirectorNewton, MA
Arnold GlazierExecutive OfficerNewton, MA
Arnold GlazierRelated PersonNewton, MA
Michael D SigmanDirectorBrookline, MA
Abid AnsariRelated PersonNewton, MA
Henry EsberDirectorSan Diego, CA
Michael J. PetitRelated PersonNewton, MA
Barry SeemanRelated PersonNewton, MA

Other filings by this issuer (11)

FiledFormOfferingSold
2026-04-23D$4.8M$4.8M
2025-07-02D/A$17.3M$10.9M
2024-07-02D/A$11.3M$7.2M
2023-12-21D/A$7.5M$6.0M
2022-11-10D/A$3.8M$3.2M
2021-11-10D/A$3.8M$2.3M
2020-12-23D/A$2.5M$1.4M
2020-07-14D/A$1.3M$730K
2019-07-09D$1.3M$445K
2017-09-05D/A$46.9M$34.8M
2015-11-16D$46.9M$31.3M

More